|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03886 TOWN HEALTH
Nominal 
0.248 -0.001 (-0.402%) | 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Turnover | 1,833,038 | 19.371% | 1,535,580 | 1,483,892 | 1,069,045 | 1,128,932 |
| Cost of Sales | (1,331,090) | 18.727% | (1,121,134) | (1,012,631) | (784,465) | (752,568) |
| Gross Profit | 501,948 | 21.113% | 414,446 | 471,261 | 284,580 | 376,364 |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | (207,693) | (4,544) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | (117,763) | -- | -- | |
| Share of Results of Asso. & JCEs | (5,319) | -64.124% | (14,826) | 32,844 | 4,181 | 36,881 | |
| Profit / (Loss) before Taxation | (120,863) | -- | 82,503 | 126,508 | (232,855) | 38,773 | |
| Taxation | (38,226) | 15.903% | (32,981) | (51,436) | (25,595) | (28,254) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (35,121) | 2.594% | (34,233) | (53,059) | (22,588) | (18,933) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (194,210) | -- | 15,289 | 22,013 | (281,038) | (8,414) | |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Finance Costs / (Income) | (8,284) | -50.717% | (16,809) | (12,425) | (39,391) | (40,877) |
| Depreciation & Amortisation | 145,629 | 14.165% | 127,560 | 122,221 | 133,980 | 135,160 |
| Directors' Emoluments | 16,101 | 25.740% | 12,805 | 3,751 | 504 | 12,913 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | -2.870 | -- | 0.210 | 0.290 | -3.730 | -0.110 |
| DPS (cts) | 0.120 | -- | 0.120 | 0.150 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | 57.143% | 51.724% | -- | -- |
| Cash flow per share ($) | 0.037 | -- | 0.006 | 0.023 | 0.004 | 0.029 |
| NBV per share ($) | 0.479 | -- | 0.511 | 0.512 | 0.506 | 0.534 |
| Remarks: | Real time quote last updated: 01/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -47,676,000 |
| %Change | -- |
| EPS / (LPS) | HKD -0.007 |
| NBV Per Share ($) | HKD 0.463 |